Key Decisions in HIV Care

Download All
Expert international faculty present biweekly Medical Minute updates with downloadable slides and podcasts on emerging data guiding key decision points in HIV care focused on the individual patient. ClinicalThought commentaries from both patients and healthcare professionals highlight unique patient needs and how best to address them.
Jonathan Appelbaum, MD, FACP, AAHIVS
Jens D. Lundgren, MD, DMSc
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Jonah Musa, MBBS, MSCI, PhD
William R. Short, MD, MPH, AAHIVS

Special Populations

In this case example, learn the latest data about whether to use tenofovir alafenamide during pregnancy.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP Released: September 15, 2021

Learn the latest data about whether to use tenofovir alafenamide during pregnancy.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP Released: September 24, 2021

Listen as Milena Murray, PharmD, MSc, BCIDP, AAHIVP, shares key data and recommendations to support the use of TAF in pregnancy.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP Released: September 29, 2021

In this on-demand recording of a live webinar, expert faculty review key considerations for the use of ART in pregnancy. Topics include current recommendations and a discussion of the data to support ART options during pregnancy.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP Jonah Musa, MBBS, MSCI, PhD Released: November 8, 2021

Learn key considerations for the use of ART in older PWH. Topics include current data and recommendations on polypharmacy, drug-drug interactions, drug-disease state interactions, and cardiovascular risk considerations

Jonathan Appelbaum, MD, FACP, AAHIVS Jens D. Lundgren, MD, DMSc Released: November 29, 2021

In this on-demand recording of a live webinar, expert faculty review key considerations for the use of ART in older PWH. Topics include current data and recommendations on polypharmacy, drug–drug interactions, drug–disease state interactions, and cardiovascular risk considerations.

Jonathan Appelbaum, MD, FACP, AAHIVS Jens D. Lundgren, MD, DMSc Released: December 21, 2021

In this case example, learn the latest data about maternal weight gain associated with ART use in pregnancy including pregnancy effects and the role of baseline maternal weight.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP Released: September 21, 2021

Learn the latest data about maternal weight gain associated with ART use in pregnancy including pregnancy effects and the role of baseline maternal weight.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP Released: September 27, 2021

Listen as Milena Murray, PharmD, MSc, BCIDP, AAHIVP, shares the latest data on maternal weight gain associated with ART use in pregnancy including pregnancy effects and the role of baseline maternal weight.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP Released: October 12, 2021

Many patients are receiving BIC/FTC/TAF as an initial ART regimen, but what should you do if these patients become pregnant?

William R. Short, MD, MPH, AAHIVS Released: October 15, 2021

Learn key considerations for the use of ART in pregnancy. Topics include current recommendations and a discussion of the data to support ART options during pregnancy.

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP Jonah Musa, MBBS, MSCI, PhD Released: October 20, 2021

Learn key considerations for the use of ART in older PWH. Topics include current data and recommendations on renal impairment and liver disease.

Jonathan Appelbaum, MD, FACP, AAHIVS Jens D. Lundgren, MD, DMSc Released: January 13, 2022
Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings